When MTSS1 expression in CLL was examined at patient level, in Oncomine, strong heterogeneity was detected, with expression levels ranging from levels lower than healthy B-lymphocytes to log2 values of four (data not shown). The gene discussed is MTSS1; the disease is B-cell chronic lymphocytic leukemia.